Reported Feb 4, 2026 · Ongoing

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle,…

Sato Pharmaceutical Co., Ltd.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Sato Pharmaceutical Co., Ltd · Ahc Building 1-5-27 · Tokyo, N/A · N/A

Is this the product you have?

  • INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle
  • Manufactured bySato Pharmaceutical Co., Ltd., NDC 49873-402-01
Lot codes and dates
  • Lot#: PWXT, Exp 1/31/2027
Amount recalled
3,640 bottles

Where it was sold

Why it was recalled

Failed Disintegration Specifications: above the time expected.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Sato Pharmaceutical Co., Ltd. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 6:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.